Some animal studies have suggested that the direct action of PPARγ on the heart could be beneficial, since TZDs improve cardiac performance [40, 41], decrease cardiac hypertrophy [42–44], and may also have beneficial effects on left ventricular remodeling and function after ischemic injury [45, 46]. Here, PPARG is linked to cardiac hypertrophy.